rs114472821

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032444.4(SLX4):​c.2924C>T​(p.Pro975Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00288 in 1,614,178 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P975P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0067 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 21 hom. )

Consequence

SLX4
NM_032444.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.265

Publications

9 publications found
Variant links:
Genes affected
SLX4 (HGNC:23845): (SLX4 structure-specific endonuclease subunit) This gene encodes a protein that functions as an assembly component of multiple structure-specific endonucleases. These endonuclease complexes are required for repair of specific types of DNA lesions and critical for cellular responses to replication fork failure. Mutations in this gene were found in patients with Fanconi anemia. [provided by RefSeq, Sep 2016]
SLX4 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group P
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032212734).
BP6
Variant 16-3590714-G-A is Benign according to our data. Variant chr16-3590714-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241677.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00666 (1014/152342) while in subpopulation AFR AF = 0.0179 (744/41574). AF 95% confidence interval is 0.0168. There are 10 homozygotes in GnomAd4. There are 489 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLX4NM_032444.4 linkc.2924C>T p.Pro975Leu missense_variant Exon 12 of 15 ENST00000294008.4 NP_115820.2 Q8IY92-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLX4ENST00000294008.4 linkc.2924C>T p.Pro975Leu missense_variant Exon 12 of 15 5 NM_032444.4 ENSP00000294008.3 Q8IY92-1

Frequencies

GnomAD3 genomes
AF:
0.00663
AC:
1010
AN:
152224
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0178
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00621
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00209
Gnomad OTH
AF:
0.00814
GnomAD2 exomes
AF:
0.00361
AC:
908
AN:
251262
AF XY:
0.00338
show subpopulations
Gnomad AFR exome
AF:
0.0168
Gnomad AMR exome
AF:
0.00431
Gnomad ASJ exome
AF:
0.00456
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00242
Gnomad OTH exome
AF:
0.00408
GnomAD4 exome
AF:
0.00249
AC:
3636
AN:
1461836
Hom.:
21
Cov.:
37
AF XY:
0.00258
AC XY:
1875
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.0182
AC:
611
AN:
33480
American (AMR)
AF:
0.00414
AC:
185
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00402
AC:
105
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.00543
AC:
468
AN:
86258
European-Finnish (FIN)
AF:
0.000394
AC:
21
AN:
53362
Middle Eastern (MID)
AF:
0.0177
AC:
102
AN:
5768
European-Non Finnish (NFE)
AF:
0.00170
AC:
1894
AN:
1112012
Other (OTH)
AF:
0.00407
AC:
246
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
262
523
785
1046
1308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00666
AC:
1014
AN:
152342
Hom.:
10
Cov.:
32
AF XY:
0.00656
AC XY:
489
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0179
AC:
744
AN:
41574
American (AMR)
AF:
0.00425
AC:
65
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00580
AC:
28
AN:
4828
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00209
AC:
142
AN:
68034
Other (OTH)
AF:
0.00758
AC:
16
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
51
103
154
206
257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00383
Hom.:
7
Bravo
AF:
0.00704
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.0123
AC:
54
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.00402
AC:
488
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00463
EpiControl
AF:
0.00362

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 05, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 31, 2012
Leiden Open Variation Database
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:curation

Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 21, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Fanconi anemia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia complementation group P Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Malignant tumor of breast Benign:1
-
Center of Medical Genetics and Primary Health Care
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.78
T
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.1
DANN
Benign
0.31
DEOGEN2
Benign
0.012
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.39
T
MetaRNN
Benign
0.0032
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
-0.20
N
PhyloP100
-0.27
PrimateAI
Benign
0.19
T
PROVEAN
Benign
0.76
N
REVEL
Benign
0.054
Sift
Benign
1.0
T
Sift4G
Benign
0.53
T
Polyphen
0.0020
B
Vest4
0.061
MVP
0.072
MPC
0.056
ClinPred
0.00030
T
GERP RS
-4.3
Varity_R
0.0097
gMVP
0.080
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114472821; hg19: chr16-3640715; API